We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSM icon
7001
FerroAtlántica
GSM
$594M
$7K ﹤0.01%
510
-684
-57% -$8.88K
HBIO icon
7002
Harvard Bioscience
HBIO
$27.5M
$7K ﹤0.01%
181
-186
-51% -$5.5K
HBM icon
7003
Hudbay
HBM
$10.1B
$7K ﹤0.01%
1,000
-4,425
-82% -$33.3K
JVA icon
7004
Coffee Holding Co
JVA
$19.5M
$7K ﹤0.01%
1,477
-1,443
-49% -$6.02K
KZIA
7005
Kazia Therapeutics
KZIA
$144M
$7K ﹤0.01%
41
+31
+310% +$4.92K
LMFA
7006
DELISTED
LM Funding America
LMFA
$7K ﹤0.01%
+1
New +$23.5K
CYPH
7007
Cypherpunk Technologies Inc
CYPH
$62.9M
$7K ﹤0.01%
+119
New +$7.48K
LXP.PRC icon
7008
LXP Industrial Trust 6.5% Series C Preferred Stock
LXP.PRC
$94.1M
$7K ﹤0.01%
146
-985
-87% -$50K
MNDO icon
7009
Mind CTI
MNDO
$19.4M
$7K ﹤0.01%
+2,822
New +$6.99K
MTEX icon
7010
Mannatech
MTEX
$9.24M
$7K ﹤0.01%
500
NNVC icon
7011
NanoViricides
NNVC
$38.8M
$7K ﹤0.01%
303
-163
-35% -$4.38K
NUWE icon
7012
Nuwellis
NUWE
$160K
0
XMAX
7013
XMAX Inc
XMAX
$548M
$7K ﹤0.01%
163
+71
+77% +$2.48K
PALI icon
7014
Palisade Bio
PALI
$330M
0
PDSB icon
7015
PDS Biotechnology
PDSB
$38.4M
$7K ﹤0.01%
+33
New +$6.82K
AGPU
7016
Axe Compute Inc
AGPU
$95.4M
$7K ﹤0.01%
2
QRHC icon
7017
Quest Resource Holding
QRHC
$26.8M
$7K ﹤0.01%
6,555
+1,650
+34% +$2.62K
SISI
7018
DELISTED
Shineco
SISI
0
TZOO icon
7019
Travelzoo
TZOO
$74.3M
$7K ﹤0.01%
800
-258
-24% -$2.41K
UPV icon
7020
ProShares Ultra FTSE Europe
UPV
$17M
$7K ﹤0.01%
118
-47
-28% -$2.5K
VNRX icon
7021
VolitionRx Ltd
VNRX
$8.65M
$7K ﹤0.01%
133
-133
-50% -$7.81K
VT icon
7022
PUT
Vanguard Total World Stock ETF
VT
$77.1B
$7K ﹤0.01%
+100
New +$6.93K
XTLB
7023
XTL Biopharmaceuticals
XTLB
$6.93M
$7K ﹤0.01%
760
-3,317
-81% -$39K
RPT
7024
Rithm Property Trust
RPT
$95.8M
$7K ﹤0.01%
+84
New +$6.88K
QXO
7025
QXO Inc
QXO
$13.8B
$7K ﹤0.01%
196
+164
+513% +$5.66K

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.